2.4.0.8120 - Disclosure - Discontinued Operations of Adeona Clinical Laboratory and Note Receivable (Details Textual)truefalsefalse1false USDfalsefalse$PAsOn06_30_2013http://www.sec.gov/CIK0000894158instant2013-06-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$PAsOn12_31_2012http://www.sec.gov/CIK0000894158instant2012-12-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$PAsOn03_08_2012_AdeonaClinicalLaboratoryLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommercialPaperMemberusgaapCreditFacilityAxishttp://www.sec.gov/CIK0000894158instant2012-03-08T00:00:000001-01-01T00:00:00falsefalsePromissory Note [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CommercialPaperMemberus-gaap_CreditFacilityAxisexplicitMemberfalsefalseAdeona Clinical Laboratory, Llc [Member]us-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldisyn_AdeonaClinicalLaboratoryLlcMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 4us-gaap_NotesReceivableNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse700000700000USD$falsetruefalse2truefalsefalse00USD$falsetruefalse3truefalsefalse700000700000USD$falsetruefalsexbrli:monetaryItemTypemonetaryNet amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor's statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor's rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Article 5 false2Financing Receivable, Net2false 4us-gaap_LongTermDebtPercentageBearingVariableInterestRateus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3truetruefalse0.0570.057falsefalsefalsenum:percentItemTypepureThe interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0Long-term Debt, Percentage Bearing Variable Interest, Percentage RatefalseDiscontinued Operations of Adeona Clinical Laboratory and Note Receivable (Details Textual) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.syntheticbiologics.com/role/DiscontinuedOperationsOfAdeonaClinicalLaboratoryAndNoteReceivableDetailsTextual32